Related Experiment Videos
Rupioid psoriasis associated with arthropathy
Abstract:
We reported a rare case of rupioid psoriasis associated with arthropathy. A 28-year-old male had suffered from severe arthritis for 6 months and had limpet-like, cone-shaped skin lesions on the extremities for 3 months. The histopathology revealed remarkable Munro's and Kogoj microabscesses, intense dermal edema, and moderate inflammatory cell infiltration. The radiological examination showed bilateral sacroilitis. The skin lesions and arthritis responded dramatically in three weeks to i.m. methotrexate combined with topical steroids and emollients and occlusive dressing technique. There was no recurrence of such skin lesions during the two year follow-up period.
Insights
This case study highlights a rare instance of rupioid psoriasis with associated arthropathy. Prompt treatment with methotrexate and topical steroids effectively resolved both the skin lesions and arthritis.
Area of Science:
- Dermatology
- Rheumatology
- Pathology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Arthropathy can be a manifestation of psoriatic disease.
- Rupioid psoriasis is a rare, distinct variant characterized by conical, layered lesions.
Observation:
- A 28-year-old male presented with severe arthritis and distinctive limpet-like, cone-shaped skin lesions.
- Histopathology confirmed features of psoriasis, including Munro's and Kogoj microabscesses.
- Radiological imaging revealed bilateral sacroiliitis, indicating joint involvement.
Findings:
- The patient experienced a dramatic response to intramuscular methotrexate combined with topical steroids, emollients, and occlusive dressings.
- Resolution of both cutaneous lesions and arthritic symptoms was achieved within three weeks.
- No recurrence of skin lesions was observed during a two-year follow-up period.
Implications:
- This case underscores the importance of recognizing and managing rare presentations of psoriatic disease.
- Early and aggressive treatment can lead to significant improvement in both skin and joint manifestations.
- Methotrexate remains a viable and effective therapeutic option for severe psoriatic arthropathy.